Brian Kiesel

1PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 28, 2024
Informing the Recommended Phase III Dose of Alnuctamab, a CD3 × BCMA T-Cell Engager, Using Population Pharmacokinetics and Exposure-Response Analysis.

Brian Kiesel, Mayu Osawa, Madhan Masilamani

Pageof 1

Frequent Collaborators

1 joint publications

Madhan Masilamani

1 joint publications

Allison Gaudy